Related references
Note: Only part of the references are listed.Atypical hemolytic uremic syndrome
Chantal Loirat et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Dense Deposit Disease Associated With Monoclonal Gammopathy of Undetermined Significance
Sanjeev Sethi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Genetics and complement in atypical HUS
David Kavanagh et al.
PEDIATRIC NEPHROLOGY (2010)
Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease
Isolmar T. Schettert et al.
THROMBOSIS RESEARCH (2010)
Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
R. S. CAMILLERI et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
ADAMTS13 P475S polymorphism causes a lowered enzymatic activity and urea lability in vitro
M. Akiyama et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Frequency of Pro475Ser polymorphism of ADAMTS13 gene and its association with ADAMTS-13 activity in the Korean population
Mun Ju Jang et al.
YONSEI MEDICAL JOURNAL (2008)
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
vAcquired ADAMTS-13 deficiency in pediatric patients with severe sepsis
Trung C. Nguyen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura
Z. Tao et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
T Ono et al.
BLOOD (2006)
Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
B Plaimauer et al.
BLOOD (2006)
Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement
M Noris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Absence of Pro475Ser polymorphism in ADAMTS-13 in Caucasians
TN Bongers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
K Kokame et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Measurement of von Willebrand factor cleaving protease (ADAMTS-13):: results of an international collaborative study involving 11 methods testing the same set of coded plasmas
A Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma:: a multicenter comparison of different assay methods
JD Studt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome
A Veyradier et al.
JOURNAL OF PEDIATRICS (2003)
Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity
K Kokame et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
G Remuzzi et al.
BLOOD (2002)
Share Paper
